A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to remove amyloid plaques from the brain ...
An experimental treatment appears to delay Alzheimer's symptoms in some people genetically destined to get the disease in ...
Research announced today is the first of its kind to suggest that anti-amyloid drugs can delay or even stop the progression ...
An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...
An experimental treatment appears to postpone Alzheimer's symptoms in some people genetically destined to get the disease at ...
For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from ...
A recent study determined the lifetime risk of developing dementia is double that of previous estimates. But there’s good ...
A groundbreaking study from University School of Medicine reveals that just 3½ years of intensive blood pressure control can ...